Magnetic Resonance Cholangio-pancreatography (MRCP) for Suspected Bilio-pancreatic Disease
This study has been completed.
Information provided by (Responsible Party):
Till Wehrmann, Deutsche Klinik fuer Diagnostik
First received: February 20, 2012
Last updated: February 23, 2012
Last verified: February 2012
The interpretation of Magnetic Resonance Cholangio-pancreatography (MRCP)-findings is primarily performed by radiologists who only in some cases have experience with the interpretation of endoscopic retrograde cholangiopancreatography (ERCP)-images. It is unclear if MRCP-interpretation by the radiologist is sufficient to decide which additional endoscopic procedures might be necessary in an individual case or if an additional MRCP-interpretation by the endoscopist renders any clinical impact.
Suspected Bilio-pancreatic Disease
||Observational Model: Cohort
Time Perspective: Prospective
||Magnetic Resonance Cholangio-pancreatography (MRCP) for Suspected Bilio-pancreatic Disease: Should the Endoscopist Take a Second Look?
Primary Outcome Measures:
Secondary Outcome Measures:
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||December 2009 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
During 1/2007 until 12/2009 consecutive patients who were referred for dedicated endoscopic procedures regarding suspected alterations of the pancreato-biliary ductal system (nearly exclusively for EUS and/or ERCP) to our unit based on actual MRCP-findings were enrolled.
- Patients aged 18 years or older who were referred for pancreato-biliary endoscopy to our unit based on actual MRCP-findings. In all cases MRCP should have been performed within 4 weeks prior admittance and a written radiological report as well as the digital images must be available.
- Patients who had any endoscopic interventions in our institution before and also patients who underwent MRCP at our hospital were excluded.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
No Contacts or Locations Provided
No publications provided
||Till Wehrmann, Head, Divison of Gastroenterology, DKD Wiesbaden, Deutsche Klinik fuer Diagnostik
History of Changes
|Other Study ID Numbers:
|Study First Received:
||February 20, 2012
||February 23, 2012
||Germany: Ethics Commission
Keywords provided by Deutsche Klinik fuer Diagnostik:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on September 16, 2014
Digestive System Diseases